Realizing the value of complex medical technology: Demonstrating cost-effectiveness is not enough

被引：0
|
作者：
Hehakaya, C. [1 ]
Frederix, G. W. J. [2 ]
van Zyp, J. R. N. van der Voort [3 ]
Grobbee, D. E. [1 ,3 ]
Verkooijen, H. M. [3 ,4 ]
机构：
[1] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Global Publ Hlth & Bioeth, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Hlth Econ Evaluat, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Div Imaging & Oncol, Utrecht, Netherlands
[4] Univ Utrecht, Utrecht, Netherlands
来源：
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY | 2023年 / 41卷
关键词：
Technologies; Innovations; Implementation; Stakeholders; Complex interventions; Evaluation; CONVERGENT INNOVATION; HEALTH-CARE; RADIOTHERAPY;
D O I：
10.1016/j.ctro.2023.100644
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The main factors driving the value of medical treatments are proven effectiveness and cost-effectiveness. This is different for complex medical technologies that combine scientific disciplines, functions or tools in a single solution-oriented method. This short communication provides three recommendations to realize the value of complex medical technologies. It is important to engage stakeholders before technology implementation to promote its relevance from multiple perspectives, to explore opportunities for professional development and collaboration, and to demonstrate the societal effects over the entire life-cycle.
引用
收藏
页数：3
相关论文
共 50 条
12345